Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sentinel Lymph Node Biopsy After Neoadjuvant Treatment on Locoregional Control of Disease in Initially Node Positive Breast Cancer Patients

NCT03833960 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.

NCT NCT03833960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sentinel Lymph Node Biopsy After Neoadjuvant Treatment on Locoregional Control of Disease in Initially Node Positive Breast Cancer Patients
Lead sponsor
Clinical Hospital Center Rijeka
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
June 30, 2019
Enrollment
65 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locoregional neoplasm recurrence, progression, disease, sentinel lymph node biopsy